Cleared Traditional

K913263 - VITALMAX 830 SERIES

K913263 is the FDA 510(k) clearance for VITALMAX 830 SERIES by Pace Tech, Inc.. It is a Class 2 Cardiovascular device (product code MHX) cleared through the Traditional 510(k) pathway after a 79-day FDA review.

K913263 · Pace Tech, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1991
Decision
79d
Days
Class 2
Risk

K913263 is an FDA 510(k) clearance for the VITALMAX 830 SERIES. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Pace Tech, Inc. (Clearwater, US). The FDA issued a Cleared decision on October 10, 1991 after a review of 79 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pace Tech, Inc. devices

Submission Details

510(k) Number K913263 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 23, 1991
Decision Date October 10, 1991
Days to Decision 79 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 125d · This submission: 79d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 199
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K913263.
PORTABLE PATIENT MONITOR
K922974 · Hewlett-Packard Co. · Dec 1992
MODELS M1175A AND M1176A COMPONENT MONITORING SYST
K922058 · Hewlett-Packard Co. · Oct 1992
MODEL M2350A AND M2360A WAVEVUE CENTRAL MONITOR
K921014 · Hewlett-Packard Co. · Oct 1992
MONARCH SYSTEM
K911051 · Baxter Healthcare Corp · Aug 1991